Variations of the P2 group in HIV-1 protease inhibitors containing a tertiary alcohol in the transition-state mimicking scaffold†
Abstract
A short synthetic protocol leading to HIV-1
* Corresponding authors
a
Department of Medicinal Chemistry, Organic Pharmaceutical Chemistry, BMC, Uppsala University, Box 574, Uppsala, Sweden
E-mail:
Anders.Hallberg@orgfarm.uu.se
Fax: +46-18-4714474
Tel: +46-18-4714284
b Medivir AB, Lunastigen 7, Huddinge, Sweden
A short synthetic protocol leading to HIV-1
J. K. Ekegren, J. Gising, H. Wallberg, M. Larhed, B. Samuelsson and A. Hallberg, Org. Biomol. Chem., 2006, 4, 3040 DOI: 10.1039/B606859F
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content